Disc Medicine enters ATM equity offering agreement for up to $59.7M with Jefferies

Disc Medicine, Inc.

Entered Open Market Sale Agreement with Jefferies to sell up to $59.7M of common stock at-the-market.
Jefferies receives 3% commission on gross proceeds from shares sold as sales agent or principal.
Company not obligated to sell any shares; offering may be terminated at any time.
Shares issued under existing S-3 registration statement (No. 333-269272) with prospectus supplement.
Agreement contains customary representations, warranties, and indemnification provisions.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Disc Medicine, Inc. entered into Open Market Sale Agreement with Jefferies LLC valued at up to $59.7 million (effective 2023-10-10).

Action: entry
Agreement: atm program
Counterparty: Jefferies LLC
Value: up to $59.7 million
Effective: 2023-10-10

Exact text from the filing

On October 10, 2023, Disc Medicine, Inc. (the “Company”) entered into an Open Market Sale Agreement SM (the “Agreement”) with Jefferies LLC (“Jefferies”), pursuant to which the Company may, from time to time in its sole discretion, issue and sell through Jefferies, acting as sales agent, or directly to Jefferies, acting as principal, shares of the Company’s common stock, par value $0.0001 per share (“common stock”).

View on SEC.gov

Browse all material agreements →

Disc Medicine, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-253519

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.